Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi(Stanford University), Edgar G. Engleman(Stanford University)
Annual Review of Pathology Mechanisms of Disease
November 16, 2020
Cited by 2,162
Related Papers
Neutrophil-activating therapy for the treatment of cancer
|Cancer Cell|2023|196
B-1a Lymphocytes Attenuate Insulin Resistance
|Diabetes|2014|109
Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity
|JCI Insight|2016|27